Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Medicine, Health Care, and Philosophy|October 10, 2025
Kidney stone disease: phenomenological perspectivesChris A Suijker, Corijn van Mazijk, Stijn RoemelingEuropean Urology|April 22, 2008
The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), RotterdamClaartje Gosselaar, Monique J Roobol, Stijn Roemeling, et al.The Prostate|April 26, 2006
Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)Stijn Roemeling, Monique J Roobol, Claartje Gosselaar, et al.Nederlands Tijdschrift Voor Geneeskunde|June 4, 2009
[The need for orchiopexy in the case of congenital undescended testis]Meelan Bul, Stijn Roemeling, A G M Zeegers, et al.Journal of Clinical Medicine|May 13, 2026
Exploratory Treatment-Selection Model of Intraoperative Cone-Beam Computed Tomography During Percutaneous Nephrolithotomy: Insights from RCT DataChris A Suijker, Riemer A Kingma, Inge M van Oort, et al.European Urology|August 29, 2006
Should we replace the Gleason score with the amount of high-grade prostate cancer?André N Vis, Stijn Roemeling, Ries Kranse, et al.European Urology|June 23, 2007
Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohortAndré N Vis, Stijn Roemeling, Ardine M J Reedijk, et al.The Prostate|October 18, 2006
Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristicsClaartje Gosselaar, Monique J Roobol, Stijn Roemeling, et al.Cancer|November 17, 2006
Metastatic disease of screen-detected prostate cancer : characteristics at diagnosisStijn Roemeling, Ries Kranse, André N Vis, et al.International Journal of Cancer|March 3, 2010
Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)Melissa Kerkhof, Monique J Roobol, Jack Cuzick, et al.Pageof 4